Foley is proud to sponsor the Food and Drug Law Institute’s (FDLI) 1st Annual Conference on Nanotechnology Law, Regulation and Policy on February 28-29, 2008 in Washington, D.C.
For its 2008 forum, the event has been carefully structured to focus on how nanotech and advanced materials are being leveraged as enabling technologies in five leading industry verticals:
- Advanced Materials
- Clean Energy/CleanTech
- Life Sciences
These industrial categories were voted by IBF’s Board of Directors and past attendees as being the leading industry verticals for which nanotechnology and advanced materials are the enabling technologies, resulting in companies and deals attractive to investors.
Foley Senior Counsel Leon Radomsky is participating on the panel titled “Making Dollars & Sense of the Business of Nanotechnology” on February 28. Nanotechnology was incorporated into more than $50 billion in manufactured goods last year, according to Lux Research. By 2014, the market will grow to $2.6 trillion. By 2011, over $15 billion in nano-enabled drugs and therapeutics will be sold – up from more than $3 billion in 2006. And industry experts project that nanotechnology will be in incorporated into $20 billion worth of consumer food products by 2010.
Yet, despite this rapid commercialization, no nano-specific regulations exists anywhere in the world. Most regulatory agencies remain in an information gathering mode – lacking the legal and scientific tools, information and resources they need to adequately oversee exponential nanotechnology market growth.